Eric Berg
Eric Berg is a health commentator who produces content on nutrition, dietary risk factors, and liver health. His published research includes work in the Journal of Clinical Medicine examining cancer metabolism, fasting, and the keto-paradox.
5 claims checked on air: 2 overstated 3 supported
What they said on air
Fructose is causing chronic liver disease in approximately 100 million Americans.
"Something that people think is harmless that's currently causing chronic liver disease in 100 million people... What is it that's causing chronic liver disease in a hundred million Americans? Fructose." (said at 0:00:00)
The estimate of approximately 75 to 100 million Americans refers to the total prevalence of nonalcoholic fatty liver disease (NAFLD / MASLD), which is the leading cause of chronic liver disease in the United States. While high intake of dietary fructose and sugar-sweetened beverages is an established risk factor for hepatic steatosis and metabolic dysfunction, NAFLD is a complex, multifactorial condition driven broadly by obesity, insulin resistance, overall caloric excess, and genetic factors. Attributing all 100 million cases of chronic liver disease directly and solely to fructose overstates its causal contribution to the total disease burden.
- context: Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic… (Gastroenterology & hepatology 2019)
"Nonalcoholic fatty liver disease (NAFLD) affects 75 to 100 million adults in the United States and is the leading cause of chronic liver disease worldwide, fueled by the rising epidemic of obesity and metabolic syndrome." (abstract, passage verified)
pubmed - context: Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management st… (Annals of the New York Academy of Sciences 2023)
"Predictive models suggest that over 100 million adults in the United States will have NAFLD by 2030, representing over a third of the population." (abstract, passage verified)
pubmedfull study (doi) - partial: Review: Fructose, the Sweet Culprit behind Nonalcoholic Fatty Liver Disease and Type 2 Dia… (Current diabetes reviews 2026)
"This elevated consumption of fructose and sugars is considered to be one of the major risk aspects for the emergence of obesity and other metabolic disorders. In this review, we discuss the correlation between insulin resistance and NAFLD (nonalcoholic fatty liver disease) due to dietary fructose intake." (abstract, passage verified)
pubmedfull study (doi)
Dietary fructose is as dangerous to the liver as alcohol.
"It is as dangerous as alcohol to your liver." (said at 0:00:15)
The comparison between fructose and alcohol stems from narrative reviews and mechanistic hypotheses (notably by Dr. Robert Lustig) pointing out parallel biochemical pathways, such as hepatic de novo lipogenesis and hepatic steatosis ('alcohol without the buzz'). However, asserting that dietary fructose is as dangerous to the liver as alcohol overstates the clinical evidence. Meta-analyses of human controlled trials show that fructose increases liver fat (intrahepatocellular lipid) primarily when consumed as excess calories (hypercaloric diets, particularly via sugar-sweetened beverages), but not when substituted isocalorically for other macronutrients. In contrast, alcohol causes direct dose-dependent hepatotoxicity, alcoholic hepatitis, and cirrhosis.
- context: Fructose: it's "alcohol without the buzz". (Advances in nutrition (Bethesda, Md.) 2013)
"Thus, fructose can exert detrimental health effects beyond its calories and in ways that mimic those of ethanol, its metabolic cousin. Indeed, the only distinction is that because fructose is not metabolized in the central nervous system, it does not exert the acute neuronal depression experienced by those imbibing ethanol. These metabolic and hedonic analogies argue that fructose should be thought of as "alcohol without the buzz."" (abstract, passage verified)
pubmedfull study (doi) - contradicts: Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or index… (The American journal of clinical nutrition 2014)
"On the basis of indirect comparisons across study findings, the apparent association between indexes of liver health (ie, liver fat, hepatic de novo lipogenesis, alanine aminotransferase, AST, and γ-glutamyl transpeptase) and fructose or sucrose intake appear to be confounded by excessive energy intake." (abstract, conclusions)
pubmedfull study (doi) - contradicts: Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease… (Nutrients 2022)
"Total fructose-containing sugars increased IHCL (standardized mean difference = 1.72 [95% CI, 1.08 to 2.36], p < 0.001) in addition trials and decreased AST in subtraction trials with no effect on any outcome in substitution or ad libitum trials. There was evidence of influence by food source with SSBs increasing IHCL and ALT in addition trials and mixed sources (with SSBs) decreasing AST in subtraction trials." (abstract, results)
pubmedfull study (doi)
Fructose promotes liver fat accumulation while simultaneously blocking hepatic fat oxidation.
"It does two devastating things at the exact same time. Number one, it activates fat accumulation. And number two, it will block the fat burning. In other words, it turns off any ability to get rid of that fat." (said at 0:00:23)
Preclinical and metabolic studies establish that hepatic fructose metabolism simultaneously stimulates de novo lipogenesis (fat accumulation) and suppresses hepatic fatty acid oxidation. In the liver, fructose bypasses standard phosphofructokinase regulation, driving lipogenic enzymes and generating malonyl-CoA and post-translational mitochondrial protein modifications (such as CPT1a acetylation), which directly inhibit carnitine palmitoyltransferase-1a (CPT1a) and suppress mitochondrial beta-oxidation.
- supports: Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translation… (Cell metabolism 2019)
"In summary, dietary fructose, but not glucose, supplementation of HFD impairs mitochondrial size, function, and protein acetylation, resulting in decreased fatty acid oxidation and development of metabolic dysregulation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Fructose and hepatic insulin resistance. (Critical reviews in clinical laboratory sciences 2020)
"These include unequivocal effects of fructose to promote de novo lipogenesis (DNL), impair fatty acid oxidation (FAO), induce endoplasmic reticulum (ER) stress and trigger hepatic inflammation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltrans… (Journal of hepatology 2023)
"KHK-C-induced acetylation is a novel mechanism by which dietary fructose augments lipogenesis and decreases fatty acid oxidation to promote the development of metabolic complications." (abstract, results, passage verified)
pubmedfull study (doi)
Between 5% and 10% of children have non-alcoholic fatty liver disease (NAFLD).
"What's really bad is 5 to 10% of children now have non-alcoholic fatty liver disease." (said at 0:00:48)
Systematic reviews and meta-analyses of epidemiological studies confirm that the prevalence of non-alcoholic fatty liver disease (NAFLD / MASLD) in the general pediatric population falls directly within the 5% to 10% range. A landmark meta-analysis estimated the pooled prevalence in children from general population studies to be 7.6% (95% CI: 5.5% to 10.3%), while a more recent global systematic review and modeling study estimated a prevalence of 7.0% (95% CI: 4.1% to 11.7%) among young people.
The fiber in whole fruit slows fructose breakdown and absorption compared to high-fructose corn syrup, which overwhelms the liver in large amounts.
"I'm not talking about the fructose in fruit that has the fiber that breaks down very, very slowly. I'm talking about high fructose corn syrup in such large amounts that it overwhelms the liver." (said at 0:01:05)
Evidence supports that dietary fiber in whole fruit physically slows digestion and carbohydrate absorption in the gut compared to free-sugar liquid sources (such as high-fructose corn syrup or fruit juices). In contrast to free-sugar beverages, which deliver rapid, concentrated boluses of fructose that undergo extensive first-pass hepatic metabolism and promote intrahepatic lipid accumulation (fatty liver), fructose consumed in whole fruit form is absorbed more slowly and is not associated with increased intrahepatic lipid content.
- supports: Dietary fructose and glucose differentially affect lipid and glucose homeostasis. (The Journal of nutrition 2009)
"Absorbed glucose and fructose differ in that glucose largely escapes first-pass removal by the liver, whereas fructose does not, resulting in different metabolic effects of these 2 monosaccharides." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Kiwifruit, carbohydrate availability, and the glycemic response. (Advances in food and nutrition research 2013)
"The cell wall component, being nonstarch polysaccharide, is undigested in the stomach and small intestine, so the component increases in relative concentration in the gut lumen where its physicochemical properties may be important in modulating carbohydrate digestion and absorption." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Fructose Intake From Fruit Juice and Sugar-Sweetened Beverages Is Associated With Higher I… (Diabetes care 2022)
"Energy-adjusted total fructose intake and energy-adjusted fructose from fruit were not associated with IHL in the fully adjusted models (P = 0.647 and P = 0.767). In contrast, energy-adjusted intake of fructose from fruit juice and SSB was associated with higher IHL in the fully adjusted models (P = 0.019 and P = 0.009)." (abstract, results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications